tetano
Editor, Senior Moderator
J Investig Med High Impact Case Rep
. Jan-Dec 2022;10:23247096211073258.
doi: 10.1177/23247096211073258.
Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
Zainab Fatima[SUP] 1 [/SUP], Blair R A Reece[SUP] 1 [/SUP], J Suzanne Moore[SUP] 1 [/SUP], Robert T Means Jr[SUP] 1 [/SUP]
Affiliations
Abstract
Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.
Keywords: COVID; COVID vaccine; autoimmune hemolytic anemia; hematology oncology; hemolysis; rheumatology.
. Jan-Dec 2022;10:23247096211073258.
doi: 10.1177/23247096211073258.
Autoimmune Hemolytic Anemia After mRNA COVID Vaccine
Zainab Fatima[SUP] 1 [/SUP], Blair R A Reece[SUP] 1 [/SUP], J Suzanne Moore[SUP] 1 [/SUP], Robert T Means Jr[SUP] 1 [/SUP]
Affiliations
- PMID: 35045762
- DOI: 10.1177/23247096211073258
Abstract
Discussion of the hematologic complications of vaccination for severe acute respiratory syndrome coronavirus-2 (COVID-19) has primarily focused on the development of vaccine-associated immune thrombosis with thrombocytopenia (VITT). Other hematologic complications are uncommon. We report the case of a patient who developed immunoglobulin G (IgG)-mediated autoimmune hemolytic anemia (AIHA) after the Moderna COVID-19 messenger ribonucleic acid (mRNA) vaccine.
Keywords: COVID; COVID vaccine; autoimmune hemolytic anemia; hematology oncology; hemolysis; rheumatology.